(JHX) James Hardie Industries - Overview
Stock: Fiber Cement, Siding, Trim, Gypsum Boards, Cement Boards
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -15.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.39 |
| Alpha | -45.48 |
| Character TTM | |
|---|---|
| Beta | 1.138 |
| Beta Downside | 0.934 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.26% |
| CAGR/Max DD | 0.01 |
Description: JHX James Hardie Industries January 03, 2026
James Hardie Industries plc (NYSE:JHX) manufactures and sells fiber cement, fiber gypsum, and cement-bonded boards across the United States, Australia, Europe, and New Zealand, operating under three geographic segments: North America Fiber Cement, Asia-Pacific Fiber Cement, and Europe Building Products.
The company’s product portfolio, marketed under the Hardie™ brand (e.g., Hardie Plank, Hardie Panel, Hardie Trim) and the fermacell and AESTUVER brands, serves both exterior applications-siding, cladding, soffit, trim-and interior uses such as walls, floors, ceilings, and fire-protection systems.
Key recent metrics: FY 2023 revenue reached approximately $2.1 billion, with an adjusted EBITDA margin of roughly 15 %; net debt/EBITDA stood at about 1.2×, indicating moderate leverage. The company reaffirmed FY 2024 revenue guidance of $2.2-$2.3 billion, driven by strong demand in the U.S. residential market.
Economic and sector drivers: (1) U.S. single-family housing starts, which have risen 8 % YoY, directly boost Hardie’s North American segment; (2) increasingly stringent building-code requirements for fire-resistant and moisture-durable materials favor fiber cement over traditional wood siding; (3) supply-chain constraints on timber and steel have shifted remodel and new-construction projects toward fiber-based alternatives.
For a deeper dive into Hardie’s valuation metrics and scenario analysis, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 192.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.47 > 1.0 |
| NWC/Revenue: 21.78% < 20% (prev 18.59%; Δ 3.19% < -1%) |
| CFO/TA 0.05 > 3% & CFO 693.5m > Net Income 192.1m |
| Net Debt (4.66b) to EBITDA (734.8m): 6.34 < 3 |
| Current Ratio: 1.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (577.4m) vs 12m ago 33.56% < -2% |
| Gross Margin: 36.27% > 18% (prev 0.40%; Δ 3587 % > 0.5%) |
| Asset Turnover: 43.24% > 50% (prev 79.14%; Δ -35.90% > 0%) |
| Interest Coverage Ratio: 3.42 > 6 (EBITDA TTM 734.8m / Interest Expense TTM 128.0m) |
Altman Z'' 1.40
| A: 0.06 (Total Current Assets 2.03b - Total Current Liabilities 1.13b) / Total Assets 14.07b |
| B: 0.12 (Retained Earnings 1.73b / Total Assets 14.07b) |
| C: 0.05 (EBIT TTM 437.4m / Avg Total Assets 9.52b) |
| D: 0.26 (Book Value of Equity 2.02b / Total Liabilities 7.75b) |
| Altman-Z'' Score: 1.40 = BB |
Beneish M -2.13
| DSRI: 1.01 (Receivables 368.0m/346.8m, Revenue 4.12b/3.94b) |
| GMI: 1.11 (GM 36.27% / 40.17%) |
| AQI: 2.33 (AQ_t 0.63 / AQ_t-1 0.27) |
| SGI: 1.05 (Revenue 4.12b / 3.94b) |
| TATA: -0.04 (NI 192.1m - CFO 693.5m) / TA 14.07b) |
| Beneish M-Score: -2.13 (Cap -4..+1) = BB |
What is the price of JHX shares?
Over the past week, the price has changed by -3.81%, over one month by +9.70%, over three months by +24.05% and over the past year by -31.04%.
Is JHX a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.6 | 20.4% |
| Analysts Target Price | 27.6 | 20.4% |
| ValueRay Target Price | 24.1 | 5.1% |
JHX Fundamental Data Overview February 02, 2026
P/E Forward = 18.3824
P/S = 3.2385
P/B = 2.1089
P/EG = 2.5263
Revenue TTM = 4.12b USD
EBIT TTM = 437.4m USD
EBITDA TTM = 734.8m USD
Long Term Debt = 4.97b USD (from longTermDebt, last quarter)
Short Term Debt = 77.0m USD (from shortTermDebt, last quarter)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.66b USD (from netDebt column, last quarter)
Enterprise Value = 18.01b USD (13.33b + Debt 5.24b - CCE 566.7m)
Interest Coverage Ratio = 3.42 (Ebit TTM 437.4m / Interest Expense TTM 128.0m)
EV/FCF = 60.50x (Enterprise Value 18.01b / FCF TTM 297.7m)
FCF Yield = 1.65% (FCF TTM 297.7m / Enterprise Value 18.01b)
FCF Margin = 7.23% (FCF TTM 297.7m / Revenue TTM 4.12b)
Net Margin = 4.67% (Net Income TTM 192.1m / Revenue TTM 4.12b)
Gross Margin = 36.27% ((Revenue TTM 4.12b - Cost of Revenue TTM 2.62b) / Revenue TTM)
Gross Margin QoQ = 32.59% (prev 37.44%)
Tobins Q-Ratio = 1.28 (Enterprise Value 18.01b / Total Assets 14.07b)
Interest Expense / Debt = 1.29% (Interest Expense 67.8m / Debt 5.24b)
Taxrate = 34.30% (221.4m / 645.4m)
NOPAT = 287.4m (EBIT 437.4m * (1 - 34.30%))
Current Ratio = 1.79 (Total Current Assets 2.03b / Total Current Liabilities 1.13b)
Debt / Equity = 0.83 (Debt 5.24b / totalStockholderEquity, last quarter 6.32b)
Debt / EBITDA = 6.34 (Net Debt 4.66b / EBITDA 734.8m)
Debt / FCF = 15.64 (Net Debt 4.66b / FCF TTM 297.7m)
Total Stockholder Equity = 3.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.02% (Net Income 192.1m / Total Assets 14.07b)
RoE = 5.98% (Net Income TTM 192.1m / Total Stockholder Equity 3.21b)
RoCE = 5.35% (EBIT 437.4m / Capital Employed (Equity 3.21b + L.T.Debt 4.97b))
RoIC = 5.08% (NOPAT 287.4m / Invested Capital 5.65b)
WACC = 7.50% (E(13.33b)/V(18.58b) * Re(10.11%) + D(5.24b)/V(18.58b) * Rd(1.29%) * (1-Tc(0.34)))
Discount Rate = 10.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 14.78%
[DCF Debug] Terminal Value 79.51% ; FCFF base≈329.6m ; Y1≈318.6m ; Y5≈315.1m
Fair Price DCF = 2.63 (EV 6.18b - Net Debt 4.66b = Equity 1.52b / Shares 579.9m; r=7.50% [WACC]; 5y FCF grow -4.56% → 2.90% )
EPS Correlation: -63.41 | EPS CAGR: -50.75% | SUE: -2.75 | # QB: 0
Revenue Correlation: 39.99 | Revenue CAGR: 10.13% | SUE: 0.02 | # QB: 0
EPS next Year (2027-03-31): EPS=1.20 | Chg30d=+0.008 | Revisions Net=+3 | Growth EPS=+7.8% | Growth Revenue=+14.8%